Tomas J. Heyman - Net Worth and Insider Trading

Tomas J. Heyman Net Worth

The estimated net worth of Tomas J. Heyman is at least $0 dollars as of 2024-11-13. Tomas J. Heyman is the Director of Akero Therapeutics Inc and owns about 0 shares of Akero Therapeutics Inc (AKRO) stock worth over $0. Details can be seen in Tomas J. Heyman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tomas J. Heyman has not made any transactions after 2023-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tomas J. Heyman

To

Tomas J. Heyman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tomas J. Heyman owns 5 companies in total, including Akero Therapeutics Inc (AKRO) , OptiNose Inc (OPTN) , and Invivyd Inc (IVVD) among others .

Click here to see the complete history of Tomas J. Heyman’s form 4 insider trades.

Insider Ownership Summary of Tomas J. Heyman

Ticker Comapny Transaction Date Type of Owner
AKRO Akero Therapeutics Inc 2023-06-16 director
OPTN OptiNose Inc 2020-12-01 director
IVVD Invivyd Inc 2022-06-22 director
LIMIT LIMIT 2022-09-15 director
LIMIT LIMIT 2023-05-31 director

Tomas J. Heyman Latest Holdings Summary

Tomas J. Heyman currently owns a total of 1 stock. Tomas J. Heyman owns 0 shares of Akero Therapeutics Inc (AKRO) as of June 16, 2023, with a value of $0.

Latest Holdings of Tomas J. Heyman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKRO Akero Therapeutics Inc 2023-06-16 0 32.38 0

Holding Weightings of Tomas J. Heyman


Tomas J. Heyman Form 4 Trading Tracker

According to the SEC Form 4 filings, Tomas J. Heyman has made a total of 1 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 26,000 shares on June 16, 2023, which brought Tomas J. Heyman around $1 Million.

Insider Trading History of Tomas J. Heyman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tomas J. Heyman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tomas J. Heyman Ownership Network

Ownership Network List of Tomas J. Heyman

No Data

Ownership Network Relation of Tomas J. Heyman

Insider Network Chart

Tomas J. Heyman Owned Company Details

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Tomas J. Heyman is the director of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Development Officer Catriona Yale , director & President & CEO Andrew Cheng , and Chief Operating Officer Jonathan Young .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Tomas J. Heyman made 1 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 26,000. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 150,584 shares made by Catriona Yale , and a net sale of 443,502 shares made by Andrew Cheng .

In summary, during the past 3 months, insiders sold 488,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 488,023 shares. During the past 18 months, 1,237,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 82,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akero Therapeutics Inc Insider Transactions

No Available Data

Tomas J. Heyman Mailing Address

Above is the net worth, insider trading, and ownership report for Tomas J. Heyman. You might contact Tomas J. Heyman via mailing address: C/o Akero Therapeutics, Inc., 170 Harbor Way 3rd Floor, South San Francisco Ca 94080.